Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice changes in their feet after starting Mounjaro: cold sensations, tingling, mild swelling, or a vague heaviness that wasn't there before. These reports are real, though the reasons behind them vary considerably — and most are not a sign that something has gone seriously wrong. As a prescription medicine, Mounjaro requires ongoing clinical oversight so that any new symptom is assessed in the right context, rather than dismissed or catastrophised. What follows is a clear account of what the evidence actually says, and how to decide what to do next.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide (the active ingredient in Mounjaro) slows gastric emptying and significantly reduces appetite. For most people that means eating and drinking less than usual, particularly in the first few weeks on each new dose. Reduced fluid intake is an underappreciated consequence: mild dehydration quietly affects circulation, and the feet, sitting at the far end of the peripheral vascular system, often feel the effects first. If you have noticed your toes feeling cold or poorly perfused, our page on what drives cold feet on Mounjaro explains the circulatory mechanisms behind that experience in more detail. Cold toes, a faint tingling, or a sense of poor circulation can all trace back to something as straightforward as not drinking enough water through the day.
Separately, the early weeks of treatment sometimes bring a degree of ankle swelling. This can seem counterintuitive on a medicine associated with weight loss, but the body's fluid balance shifts during significant dietary change, and some people retain a little fluid temporarily before it settles. The NHS patient information for tirzepatide notes that peripheral oedema has been reported in trials, so this is a recognised pattern rather than an unexpected one.
A third thread is purely mechanical. Fat pads under the heel and ball of the foot thin naturally with sustained weight loss. That layer acts as cushioning; when it reduces, feet that have worked for years with a certain amount of padding can feel different, sometimes sore, sometimes strangely sensitive to temperature. It is an adjustment, not damage.
Tingling in the hands and feet is something our prescribers hear about fairly regularly. The most common explanation is transient, postural, circulatory, or related to the changes in food and fluid intake described above. For people who had undiagnosed or borderline type 2 diabetes before starting Mounjaro, improving blood glucose control can itself cause temporary nerve sensations as the peripheral nervous system readjusts. Counterintuitively, better metabolic control can precede a period of heightened nerve sensitivity.
Where tingling deserves closer attention is when it is persistent, affects only one limb, spreads, or comes with weakness. Those patterns suggest something unrelated to tirzepatide is worth investigating. If you are already thinking about whether tingling in both hands and feet fits a pattern you've noticed, that page goes into the possible mechanisms in more detail. The key clinical distinction is bilateral and mild versus unilateral and progressive, the latter warrants a prompt GP call.
Neuropathy from long-standing diabetes is a genuine consideration for some patients. Mounjaro does not cause peripheral neuropathy, but it also does not cure pre-existing nerve damage. If your feet were already showing signs before starting treatment, monitoring them carefully remains important.
Cold sensations in the feet are among the more frequently searched Mounjaro experiences. If you want to understand the full picture, including whether Mounjaro can cause cold feet and what the physiological reasons behind it are, that page covers the evidence in depth, but the short version is this: tirzepatide can lower blood pressure modestly in some people, and reduced peripheral blood flow follows. Feet feel cold when less warm blood reaches them. This is not unique to Mounjaro (other weight-loss medicines and significant calorie restriction can do the same) but the effect can be noticeable, particularly in the evening or first thing in the morning.
Practical responses include keeping well hydrated (aiming for the NHS-recommended six to eight glasses of fluid a day, adjusting if you are exercising), wearing warmer socks than you think you need, and mentioning it at your next prescriber review. Whether the cold sensation is circulatory, related to lower body weight, or something pre-existing is exactly the kind of question a prescriber can help you think through. It is rarely an emergency, but it is worth raising rather than quietly tolerating.
Mild, bilateral ankle swelling that appeared after starting Mounjaro and has remained stable is usually the kind of thing to mention at your next review rather than treat as urgent. One foot significantly more swollen than the other is different. So is swelling accompanied by redness, warmth, or skin that pits when you press it. Deep vein thrombosis, though uncommon, can present this way and requires same-day assessment.
More broadly, any new foot or leg symptom that is getting worse rather than improving over two to three weeks, or that is affecting your ability to walk comfortably, deserves clinical input sooner rather than later. You can reach the nume aftercare team seven days a week, or contact your GP or NHS 111 if you need urgent input outside those hours.
It is also worth noting that significant weight loss changes the mechanical load on feet and ankles over time. Footwear that fitted well at a higher weight can become ill-fitting, altering gait and putting pressure on new areas. Something as simple as reassessing your shoes can make a meaningful difference to how your feet feel day to day, a detail that does not always make it into the side-effect discussion but is genuinely relevant after several months on treatment.
If you are weighing up starting treatment and want to understand the full picture of what Mounjaro involves, the Mounjaro overview sets out the evidence, the licensing, and what to expect from the first weeks. Some people also ask about whether Mounjaro is connected to anorexia, given how dramatically it can suppress appetite, and that page addresses the distinction between the medicine's intended effect and disordered eating in a straightforward way. And if the cost of private treatment is part of your thinking, the Mounjaro cost page explains honestly how pricing works and what a transparent private prescription should include.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.